Loading…

Abstract 21168: Heart Failure With Preserved Ejection Fraction (HFpEF) Outcomes After Same Hospital Readmission versus Different Hospital Readmission

Abstract only Introduction: Heart failure with preserved ejection fraction(HFpEF) is a syndromemwith limited treatment modalities. Our control over 30 day readmissions and readmission outcomes is limited. Methods: HCUP’s Nationwide Readmissions Database (NRD) from 2013-14 was used for HFpEF related...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2017-11, Vol.136 (suppl_1)
Main Authors: Patel, Nilay V, Arora, ShilpKumar, Sabhrawal, Sera, Kumar, Varun, Tripathi, Byomesh, Aneja, Ekta, Sharma, Kriti, Dave, Mihir, Patel, Neil, Setarah, Sam, Kondoor, Vishwa, Mishra, Abhishek, Bhatia, Subir, Bharadwaj, Bhaskar, Patel, Smit, Malik, Priti, Gidwani, Umesh, Gopalan, Radha
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only Introduction: Heart failure with preserved ejection fraction(HFpEF) is a syndromemwith limited treatment modalities. Our control over 30 day readmissions and readmission outcomes is limited. Methods: HCUP’s Nationwide Readmissions Database (NRD) from 2013-14 was used for HFpEF related hospitalizations using ICD-9- CM diagnostic code:428.3x in primary diagnosis field. 30-day readmissions were identified and classified into two groups: same-hospital readmissions and different-hospital readmissions. A comparative analysis was conducted focused on three metrics - mortality, length of stay (LOS) and cost of hospitalization. We used hierarchical two-level modeling and propensity score matching to adjust for confounders. Results: Of the 94,988 readmitted patients (age >65 years: 79%, Females: 61.45%) - 76,665 (80.70%) to the same hospital and rest to different hospitals. After adjusting extensive list of confounders, same hospital readmission was associated with better outcomes including in hospital mortality (OR: 0.73, 95% CI: 0.66 - 0.80, p
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.136.suppl_1.21168